Correlation Between Revolution Medicines and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Puma Biotechnology, you can compare the effects of market volatilities on Revolution Medicines and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Puma Biotechnology.
Diversification Opportunities for Revolution Medicines and Puma Biotechnology
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Revolution and Puma is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Revolution Medicines and Puma Biotechnology
Given the investment horizon of 90 days Revolution Medicines is expected to under-perform the Puma Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Revolution Medicines is 2.6 times less risky than Puma Biotechnology. The stock trades about -0.14 of its potential returns per unit of risk. The Puma Biotechnology is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 278.00 in Puma Biotechnology on October 20, 2024 and sell it today you would earn a total of 19.00 from holding Puma Biotechnology or generate 6.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Revolution Medicines vs. Puma Biotechnology
Performance |
| Timeline |
| Revolution Medicines |
| Puma Biotechnology |
Revolution Medicines and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revolution Medicines and Puma Biotechnology
The main advantage of trading using opposite Revolution Medicines and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |